Silicon Biodevices Inc is categorized under Research and Development Laboratories in Palo Alto, CA and active since 2009.
Silicon Biodevices Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Tayson Siegel at the company’s single location by writing to 1400 Arcadia Place, Palo Alto, California CA 94303 or by phoning (650) 465-3798. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Silicon Biodevices Inc |
Contact Person: | Tayson Siegel |
Address: | 1400 Arcadia Place, Palo Alto, California 94303 |
Phone Number: | (650) 465-3798 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Silicon Biodevices Inc was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Tayson Siegel for inquiries that concern Silicon Biodevices Inc by calling the company number (650) 465-3798, as your correspondence is most welcome. Additionally, the physical location of the single location of Silicon Biodevices Inc can be found at the coordinates 37.450171,-122.140791 as well as the street address 1400 Arcadia Place in Palo Alto, California 94303.
For its online presence, you may visit Silicon Biodevices Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.